A detailed history of Lpl Financial LLC transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 19,094 shares of BMEA stock, worth $76,566. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,094
Previous 24,094 20.75%
Holding current value
$76,566
Previous $108,000 77.78%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$4.23 - $10.1 $21,150 - $50,500
-5,000 Reduced 20.75%
19,094 $192,000
Q2 2024

Aug 07, 2024

SELL
$4.14 - $15.3 $125,752 - $464,737
-30,375 Reduced 55.77%
24,094 $108,000
Q1 2024

May 10, 2024

BUY
$13.92 - $19.5 $311,362 - $436,176
22,368 Added 69.68%
54,469 $814,000
Q4 2023

Feb 14, 2024

BUY
$8.37 - $19.8 $268,685 - $635,599
32,101 New
32,101 $466,000

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $117M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.